Extendicare FY26 Q2 adjusted EBITDA rises 71.7% to $68.3 million; revenue increases to $611 million

PUBT · 1d ago
Extendicare FY26 Q2 adjusted EBITDA rises 71.7% to $68.3 million; revenue increases to $611 million
  • Extendicare posted net earnings of $30.85 million, down 3.37% from Q2 2025, as revenue climbed 59.36% to $611.04 million.
  • Non-IFRS adjusted EBITDA jumped 71.7% to $68.33 million, driven mainly by CBI Home Health and Closing the Gap acquisitions.
  • Home health care average daily volume more than doubled to 77,478, lifted by 33,609 from CBI Home Health.
  • Completed the CBI Home Health acquisition for $570 million, assuming about $17.3 million of lease liabilities.
  • Issued $450 million of 4.345% senior unsecured notes due April 2031, repaying secured debt and shifting to an investment-grade unsecured structure.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Extendicare Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608061700NEWSFILECNPR____20260806_308368_1) on August 06, 2026, and is solely responsible for the information contained therein.